Filing Details
- Accession Number:
- 0001209191-19-057821
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-22 16:59:40
- Reporting Period:
- 2019-11-20
- Accepted Time:
- 2019-11-22 16:59:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
718937 | Staar Surgical Co | STAA | Ophthalmic Goods (3851) | 953797439 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1781933 | C. Graydon Hansen | 25651 Atlantic Ocean Drive Lake Forest CA 92630 | Sr. Vp, Global Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-11-20 | 17,083 | $35.02 | 8,334 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-11-22 | 9,076 | $9.30 | 17,410 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-11-22 | 4,862 | $7.52 | 22,272 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Options | Acquisiton | 2019-11-22 | 9,076 | $9.30 | 9,076 | $9.30 |
Common Stock | Common Stock Options | Acquisiton | 2019-11-22 | 4,862 | $7.52 | 4,862 | $7.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,881 | 2018-03-21 | 2027-03-20 | No | 4 | M | Direct |
0 | 2017-03-18 | 2026-03-17 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.05, inclusive.
- Reflects Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 6,250 RSUs on March 21, 2020, and lapse as to 2,084 RSUs on November 13, 2020.
- The options granted became exercisable as follows: 1/3 on 3/21/2018 and the remaining 2/3 of such options became exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/21/2020.
- The options granted became exercisable as follows: 1/3 on 3/18/2017 and 2/3 of such options became exercisable over the following 24 months in equal amounts on a monthly basis.